Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Candel Therapeutics (CADL) Q2 2025 Earnings
CADL
13
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.74
-0.45
-0.16
0.13
Details
Expected EPS
-0.37462
Actual EPS
0.13
Surprise EPS
0.5
Surprise Percent
+134.7%
Description
Candel Therapeutics (CADL) has reported earnings of 0.13 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login